A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-instit...

por Huo, Teh-Ia, Ho, Shu-Yein, Liao, Jia-I
Publicado 2023

A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on he...

por Huo, Teh-Ia, Ho, Shu-Yein, Liao, Jia-I
Publicado 2023

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade

por Liao, Jia-I, Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Lei, Hao-Jan, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023